Chemotherapy Decreases Epiphyseal Strength and Increases Bone Fracture Risk

Clinical Orthopaedics and Related Research

Volumn 413, Issue , 2003, Pages 243-254

  Van Leeuwen, Barbara L ^a   Verkerke, Gerard J ^b   Hartel, Rene M ^a   Sluiter, Willem J ^a   Kamps, Willem A ^a   Jansen, Henk W B ^c   Hoekstra, Harald J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Preclinical Assessment Group   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; METHOTREXATE;

ANIMAL MODEL; ARTICLE; BIOMECHANICS; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BONE STRENGTH; CANCER CHEMOTHERAPY; EPIPHYSIOLYSIS; EPIPHYSIS; FEMUR FRACTURE; FRACTURE; GROWTH PLATE; MALE; MALNUTRITION; NONHUMAN; PRIORITY JOURNAL; RAT; RISK; SHEAR STRESS; TIBIA FRACTURE; WEIGHT REDUCTION; ANIMAL; DRUG EFFECT; NUTRITIONAL DISORDER; PATHOPHYSIOLOGY; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMECHANICS; BODY WEIGHT; EPIPHYSES; FRACTURES, BONE; MALE; NUTRITION DISORDERS; RATS; RATS, WISTAR;

EID: 0347355195     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000073348.50837.f2     Document Type: Article

References (42)

1. Abramson EC, Chang J, Mayer M, et al: Effects of cisplatin or parathyroid hormone- and human lung tumor-induced bone resorption. J Bone Miner Res 3:541-546, 1988.
2. Abramson EC, Gajardo H, Kukreja SC: Hypocalcemia in cancer. Bone Miner 10:161-169, 1990.
3. Aisenberg J, Hsieh K, Kalaitzoglou G, et al: Bone mineral density in young adults survivors of childhood cancer. J Pediatr Hemotal Oncol 20:241-245, 1998.
4. Alexander CJ: Effect of growth rate on the strength of the growth plate-shaft junction. Skeletal Radiol 1:67-76, 1976.
5. Arikoski P, Komulainen J, Riikonen P, et al: Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child 80:143-148, 1999.
6. Arikoski P, Komulainen J, Voutilainen R, et al: Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 20:234-240, 1998.
7. Balis FM, Holcenberg JS, Poplack DG: General Principles of Chemotherapy. In Pizzo PA, Poplack DG (eds). Principles and Practice of Pediatric Oncology. Ed 3. Philadelphia, Lippincott-Raven 215-272, 1997.
8. Barth E, Roenningen H, Solheim LF, Saethren B: Effect of cis-platinum on bone ingrowth into porous fiber titanium: Mechanical and biochemical correlation. Int J Oral Maxillofac Implants 1:123-127, 1986.
9. Crofton PM, Ahmed SF, Wade JC, et al: Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia. Pediatr Res 48:490-496, 2000.
10. Ekeland A, Engesaeter LB, Langeland N: Mechanical properties of fractured and intact rat femora evaluated by bending, torsional and tensile test. Acta Orthop Scand 52:605-613, 1981.
11. El-Miedany YM, Abubakr IH, El-Baddini M: Effect of low dose methotrexate on marker of bone metabolism in patients with rheumatoid arthritis. J Rheumatol 25:2083-2087, 1998.
12. Ferretti JL, Capozza R, Mondelo N, Montuori E, Zanchetta JR: Determination of femur structural properties by geometric and material variable as a function of body weight in rats: Evidence of a sexual dimorphism. Bone 14:265-270, 1993.
13. Ferritti JL, Capozza RF, Mondelo N, Zanchetta JR: Interrelationships between densitometric, geometric, and mechanical properties of rat femora: Inferences concerning mechanical regulation of bone modeling. J Bone Miner Res 8:1389-1396, 1993.
14. Ferretti JL, Tessaro RD, Delgado CJ, et al: Biomechanical performance of diaphyseal shafts and bone tissue of femurs from protein-restricted rats. Bone Miner 4:329-339, 1988.
15. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE: Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother Rep 50:219-244, 1966.
16. Friedlaender GE, Tross RB, Doganis AC, Kirkwood JM, Baron R: Effects of chemotherapeutic agents on bone: I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg 66A:602-607, 1984.
17. Hale GA, Marina NM, Jones WD, et al: Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol 21:115-122, 1999.
18. Henderson NK, Price RI, Cole JH, Gutteridge DH, Bhagat CI: Bone density in young women is associated with body weight and muscle strength but not dietary intakes. J Bone Miner Res 10:384-393, 1995.
19. May KP, Mercill D, McDermott MT, West SG: The effect of methotrexate on mouse bone cells in culture. Arthritis Rheum 39:489-494, 1996.
20. May KP, West SG, McDermott MT, Huffer WE: The effect of low-dose methotrexate on bone metabolism and histomorphometry in rats. Arthritis Rheum 37:201-206, 1994.
21. Meister B, Gassner I, Streif W, Dengg K, Fink FM: Methotrexate osteopathy in infants with tumors of the central nervous system. Med Pediatr Oncol 23:493-496, 1994.
22. Neglia JP, Nesbit Jr ME: Care and treatment of long-term survivors of childhood cancer. Cancer 71:3386-3391, 1993.
23. Pelker RR, Friedlaender GE, Panjabi MM, et al: Chemotherapy-induced alterations in the biomechanics of rat bone. J Orthop Res 3:91-95, 1985.
24. Pfeilschifter J, Diel I: Osteoporosis due to cancer treatment: Pathogenesis and management. J Clin Oncol 18:1570-1593, 2000.
25. Reed E: Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat Rev 24:331-344, 1998.
26. Reobuck DJ: Skeletal complications in pediatric oncology patients. RadioGraphics 19:873-885, 1999.
27. Ruff CB: Body size, body shape, and long bone strength in modern humans. J Hum Evol 38:269-290, 2000.
28. Salter RB: Injuries of the epiphyseal plate. Instr Course Lect 41:351-359, 1992.
29. Shires R, Avioli LV, Bergfeld MA, et al: Effects of semistarvation on skeletal homeostasis. Endocrinology 107:1530-1535, 1980.
30. Spector WS: Handbook of Biological Data. Philadelphia, WB Saunders Company 175, 1956.
31. Spengler DM, Evans R, Baylink DJ, Spolek GA: Epiphyseal plate shear strength in rats treated with a diphosphonate. Proc Soc Exp Biol Med 165:486-489, 1980.
32. Svensson O, Hjerpe A, Reinholt FP, Engfeldt B: The effect of manganese ingestion, phosphate depletion, and starvation on the morphology of the epiphyseal growth plate: A stereologic study. Clin Orthop 197:286-294, 1985.
33. van Leeuwen BL, Hartel RM, Jansen HW, Kamps W, Hoekstra HJ: The effect of chemotherapy on the morphology of the growth plate and metaphysis of the growing skeleton. Eur J Surg Oncol 29:49-58, 2003.
34. van Leeuwen BL, Kamps WA, Hartel RM, et al: Effect of single chemotherapeutic agents on the growing skeleton of the rat. Ann Oncol 11:1121-1126, 2000.
35. van Leeuwen BL, Kampe WA, Jansen HWB, Hoekstra HJ: Review: The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 26:363-376, 2000.
36. Veth RP, De-Graaf SSN, Den-Heeten GJ, et al: Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumour resection and endoprosthesis: Report of four fractures in two children. J Surg Oncol 26:40-46, 1984.
37. Von-Hoff DD, Schilsky R, Reichert CM, et al: Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep 63:1527-1531, 1979.
38. Wainwright SA, Biggs WD, Currey JD, Gosline JM: Mechanical Design in Organism. London, Edward Arnold Ltd 183-184, 1976.
39. Wallach S: Effects of magnesium on skeletal metabolism. Magnes Trace Elem 9:1-14, 1990.
40. Wheeler DL, Vander GR, Wronski TJ, et al: The short- and long-term effects of methotrexate on the rat skeleton. Bone 16:215-221, 1995.
41. Wijnands M, Burgers A: Stress fracture in long term methotrexate treatment for psoriatic arthritis. Ann Rheum Dis 60:736-738, 2001.
42. Young DR, Shih LY, Rock MG, et al: Effects of cisplatin chemotherapy on extracortical tissue formation in canine diaphyseal segmental replacement. J Orthop Res 15:773-780, 1997.